Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population.

Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. Abstract Text:

    tomomitsu taharaTomomitsu Tahara,tomiyasu arisawaTomiyasu Arisawa,tomoyuki shibataTomoyuki Shibata,ichiro hirataIchiro Hirata,hiroshi nakanoHiroshi Nakano,tomomitsu taharaTomomitsu Tahara,tomiyasu arisawaTomiyasu Arisawa,tomoyuki shibataTomoyuki Shibata,ichiro hirataIchiro Hirata,hiroshi nakanoHiroshi Nakano,

    BACKGROUND AND AIMS: Host genetic factors play a key role in gastric carcinogenesis, but the mechanism has not been clarified. The multi-drug resistance 1 (MDR1) gene mediates the expression of P-glycoprotein, which has a role in active transport of various substrates, including xenobiotics, and thus has a protective function in various tissues and organs like gastrointestinal epithelial cells. C3435T polymorphism in exon 26 of the MDR1 gene influences P-glycoprotein expression and activity in the gastrointestinal tract. We investigated the influences of MDR1 gene polymorphism on the risk of gastric cancer. METHOD: The study was performed on 157 patients with gastric cancer (GC) and 104 patients without GC as the control group. C3435T polymorphism of MDR1 was investigated by PCR-RFLP in all of the patients. RESULTS: The MDR1 3435 TT genotype showed a significantly higher frequency in controls than in GC patients (OR = 0.43; 95% CI = 0.23-0.79). There were no significant differences of the CT and CC genotype frequencies between GC patients and controls. We also found that the 3435TT genotype of MDR1 was associated with a lower risk of non-cardiac cancer (OR = 0.42; 95% CI = 0.23-0.79), middle-third cancer (OR = 0.36; 95% CI = 0.17-0.77), advanced cancer (OR = 0.31; 95% CI = 0.13-0.73), venous invasion (OR = 0.30; 95% CI = 0.10-0.91), and lymph node metastasis (OR = 0.28; 95% CI = 0.13-0.65). CONCLUSION: Our data suggest that 3435T/T polymorphism of MDR1 is associated with a reduced risk of gastric cancer in the Japanese population.

    Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. Publishing Authors By Initials

    t taharaT Tahara,t arisawaT Arisawa,t shibataT Shibata,i hirataI Hirata,h nakanoH Nakano,t taharaT Tahara,t arisawaT Arisawa,t shibataT Shibata,i hirataI Hirata,h nakanoH Nakano,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of gastroenterology and hepatology

    VOLUME: 22

    Page Numbers: 1678-82

    Journal Abbreviation: J. Gastroenterol. Hepatol.

    ISSN: 0815-9319

    DAY: 29

    MONTH: 06

    YEAR: 2007

    Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8607909

    Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population.

    AFFILIATION: Department of Gastroenterology, School of Medicine, Toyoake, Aichi, Japan. tomomiccyu@yahoo.co.jp

    Country: Australia

    Australia Research PublicationAustralia Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Gastroenterol Hepatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News